stella
beta
Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study — Stella
Home
/
Neurofibromatosis Type 1
/
View on ClinicalTrials.gov
Recruiting
Back to Neurofibromatosis Type 1 trials
Trial locations
(1 site)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland